Research

Built on Careful Science

We describe how we test our models and publish the results as they are, including the ones that are not good yet.

Methodology

Validation Approach

LOSO Cross-Validation

Leave-one-subject-out cross-validation goes through every subject in the dataset, training on all the others and testing on the one held out. No data from the test subject reaches training, which is the closest a retrospective study gets to meeting a new patient.

External Testing

Internal results are only half the picture, so we also test on cohorts the model has never seen. On the Healthy Brain Network cohort (N=321, ages 5 to 17), Neuraxis-Child scored AUC 0.519, which is chance level. We report that result here because it is the most important limit of the current model.

Why These Choices Matter

Much of the published EEG-ML literature reports inflated performance using k-fold cross-validation, which can leak within-subject information across folds. LOSO gives more realistic estimates. Testing on an independent cohort shows whether a model has learnt something about the condition or only about one dataset.

Results

Performance Results

All results come from LOSO cross-validation. They are preliminary research metrics, not clinical performance claims.

Neuraxis-Child v1.0

Prototype · Research Use Only

AUC

0.650

Balanced Accuracy

0.595

Validation

LOSO CV

Dataset

IEEE ADHD

Age Range

7-12 years

Neuraxis-Adult v1.0

Under revalidation · Research Use Only

AUC

Not reported

Balanced Accuracy

Not reported

Validation

LOSO CV

Dataset

TDBRAIN (N=72)

Age Range

18-35 years

Internal LOSO results on the IEEE cohort. On an independent external cohort (HBN-EEG, N=321, ages 5 to 17) Neuraxis-Child scored AUC 0.519, which is chance level. All reported metrics are preliminary research results. Research Use Only (RUO).

Data

Research Datasets

IEEE ADHD Dataset

Full dataset · Ages 7-12

Public paediatric EEG dataset with clinical ADHD diagnoses. Chosen because its labels are clinician-confirmed diagnoses (not self-report) and it has been used in other published ADHD-EEG studies, so results can be compared.

TDBRAIN

N=72 subset · Ages 18-35

Lifespan EEG database (ages 5 to 89) from the Brainclinics Foundation, Nijmegen, The Netherlands (van Dijk et al., 2022). Used to study ADHD in adults recorded on different equipment from the paediatric data. The 72-subject subset covers the adult ADHD age range; the adult module is under revalidation.

HBN-EEG

N=321 · Ages 5-17 · External test only

Healthy Brain Network resting-state EEG, 105 ADHD and 216 control. Kept completely separate from training and used only to test whether Neuraxis-Child generalises to a new, community-recruited cohort.

In Preparation

Publications

We are preparing our first publications. Updates will be shared here and on our LinkedIn page.

Commitment to Open Science

All our validation uses publicly available datasets. We report conservative LOSO metrics rather than optimistic k-fold estimates, and we document our methods so others can check them.

Working in EEG research or clinical neuroscience?

We are looking for research and clinical partners to help validate SynapCore.